Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
about
Immunotherapy strategies for multiple myeloma: the present and the futureActive specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trialsCompartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune functionHLA class I binding of HBZ determines outcome in HTLV-1 infection.Cancer immunotherapy targeting Wilms' tumor gene WT1 product.Immunotherapy of multiple myeloma: the start of a long and tortuous journey.Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myelomaThe development of novel immunotherapeutic approaches in multiple myeloma.Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.T cell-based targeted immunotherapies for patients with multiple myeloma.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation.Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes.Wilms' tumour gene 1 (WT1) in human neoplasia.
P2860
Q27021939-A4FB82A7-7D39-4598-A359-FD085ACCADA6Q27026836-A27430C2-C192-4117-815F-2DFEDAF0E68CQ28383385-C465CEB3-CF6A-46F0-B462-B36FA7E47852Q33707746-20D41829-F9CC-4227-9780-CDA3FA3E9940Q36238704-983E5017-8F5A-4A72-8DA2-16DD34041ABBQ36689152-F83E1BD0-7E64-4F1C-84B0-73B2EA922A01Q36844954-C516C7D8-5894-4C01-9B77-8B02AF1B1F00Q37088532-484E5281-E08C-4BA3-95AF-5B358BE51329Q37089674-6ACAD4AC-E6F8-4494-8D3D-2F2CFF5CEBC6Q37132883-EA0FC794-B157-4FB0-AA54-D92159AADC33Q37445265-F797F9B8-1D78-4939-A215-39FB07BE0ADBQ37635023-6EEF719E-E566-4EF5-8005-8EFAC3883F59Q37731720-E31A9A8D-E31D-4212-B116-73C84DA47642Q38014834-296DE920-8D27-443A-A37E-50EAE8174FE4Q38246639-6DC2E5B3-EA84-4400-804F-79C2DD195B44Q38815399-FA22A815-1B7C-43BE-8C75-CA77006103FBQ39264030-96489F20-0395-4820-BA8D-3FE3859DF762Q39990744-6FAF967A-42FC-4951-AC66-9D8665D5BFABQ52938297-EA778139-AF86-4400-BECA-005F9D53F62F
P2860
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Myeloma cells are highly sensi ...... cific cytotoxic T lymphocytes.
@en
type
label
Myeloma cells are highly sensi ...... cific cytotoxic T lymphocytes.
@en
prefLabel
Myeloma cells are highly sensi ...... cific cytotoxic T lymphocytes.
@en
P2093
P1476
Myeloma cells are highly sensi ...... cific cytotoxic T lymphocytes.
@en
P2093
Christopher J Froelich
Kiyotaka Kuzushima
Masaki Yasukawa
Shigeru Fujita
Taichi Azuma
Takemi Otsuki
P304
P356
10.1158/1078-0432.CCR-04-0825
P407
P577
2004-11-01T00:00:00Z